 | • レポートコード：MRC2301H029 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、245ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の市場調査によると、2021年の1,592.11百万ドルであった世界の腫瘍情報システム市場規模は、2022年には1,733.18百万ドルへ達し、2027年までに年平均9.11%成長して2,687.08百万ドルへ拡大すると予想されています。本調査資料では、腫瘍情報システムの世界市場を調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、ソリューション別（高度な視覚化・画像解析ソリューション、小線源療法治療計画システム、化学療法情報システム、臨床意思決定支援システム、その他）分析、サービス別（コンサルティング/最適化サービス、実装サービス、販売後・メンテナンスサービス）分析、用途別（腫瘍内科、放射線腫瘍科、外科腫瘍科）分析、エンドユーザー別（アブレーションケアセンター・がんケアセンター、政府機関、病院・画像診断センター、研究施設）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの項目を掲載しています。また、当書ではAccuray Incorporated、Advanced Data Systems Corporation、Allscripts Healthcare Solutions, Inc.、Altai AS、CureMD.com, Inc.、DOSIsoft SA、Elekta AB、EndoSoft LLC、Epic Systems Corporation、F. Hoffmann-La Roche AG、Flatiron Health, Inc.、GE Healthcare、International Business Machines Corporation、Koninklijke Philips N.V.、McKesson Corporationなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の腫瘍情報システム市場規模：ソリューション別 - 高度な視覚化・画像解析ソリューションにおける市場規 - 小線源療法治療計画システムにおける市場規 - 化学療法情報システムにおける市場規 - 臨床意思決定支援システムにおける市場規 - その他ソリューションにおける市場規 ・世界の腫瘍情報システム市場規模：サービス別 - コンサルティング/最適化サービスにおける市場規模 - 実装サービスにおける市場規模 - 販売後・メンテナンスサービスにおける市場規模 ・世界の腫瘍情報システム市場規模：用途別 - 腫瘍内科における市場規 - 放射線腫瘍科における市場規 - 外科腫瘍科における市場規 ・世界の腫瘍情報システム市場規模：エンドユーザー別 - アブレーションケアセンター・がんケアセンターにおける市場規模 - 政府機関における市場規模 - 病院・画像診断センターにおける市場規模 - 研究施設における市場規模 ・世界の腫瘍情報システム市場規模：地域別 - 南北アメリカの腫瘍情報システム市場規模 アメリカの腫瘍情報システム市場規模 カナダの腫瘍情報システム市場規模 ブラジルの腫瘍情報システム市場規模 ... - アジア太平洋の腫瘍情報システム市場規模 日本の腫瘍情報システム市場規模 中国の腫瘍情報システム市場規模 インドの腫瘍情報システム市場規模 韓国の腫瘍情報システム市場規模 台湾の腫瘍情報システム市場規模 ... - ヨーロッパ/中東/アフリカの腫瘍情報システム市場規模 イギリスの腫瘍情報システム市場規模 ドイツの腫瘍情報システム市場規模 フランスの腫瘍情報システム市場規模 ロシアの腫瘍情報システム市場規模 ... - その他地域の腫瘍情報システム市場規模 ・競争状況 ・企業情報 |
The Global Oncology Information Systems Market size was estimated at USD 1,592.11 million in 2021 and expected to reach USD 1,733.18 million in 2022, and is projected to grow at a CAGR 9.11% to reach USD 2,687.08 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Oncology Information Systems to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Solutions, the market was studied across Advanced Visualization & Image Analysis Solutions, Brachytherapy Treatment Planning Systems, Chemotherapy Information System, Clinical Decision Support Systems, Clinical Integration Solutions, Laboratory Information Systems, Oncology Electronic Medical Record (EHR), Patient Information Systems, Picture archiving & communication System (PACS) & VNA, Population Health Management, Radiation Dose Management Solutions, Radiology Information systems, Radiotherapy Treatment Planning Systems, Treatment Management Systems & Medical Image Analysis Systems, and Treatment Planning Systems.
Based on Service, the market was studied across Consulting/Optimization Services, Implementation Services, and Post-Sale & Maintenance Services.
Based on Application, the market was studied across Medical Oncology, Radiation Oncology, and Surgical Oncology.
Based on End User, the market was studied across Ablation Care Centers & Cancer Care Centers, Government Institutions, Hospitals & Diagnostic Imaging Centers, and Research Facilities.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Oncology Information Systems market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Oncology Information Systems Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Oncology Information Systems Market, including Accuray Incorporated, Advanced Data Systems Corporation, Allscripts Healthcare Solutions, Inc., Altai AS, CureMD.com, Inc., DOSIsoft SA, Elekta AB, EndoSoft LLC, Epic Systems Corporation, F. Hoffmann-La Roche AG, Flatiron Health, Inc., GE Healthcare, International Business Machines Corporation, Koninklijke Philips N.V., McKesson Corporation, MICA Information Systems, Inc., MIM Software Inc., Oracle Corporation, Prowess Inc., RaySearch Laboratories AB, Siemens Healthineers AG, and UnitedHealth Group.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Oncology Information Systems Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Oncology Information Systems Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Oncology Information Systems Market?
4. What is the competitive strategic window for opportunities in the Global Oncology Information Systems Market?
5. What are the technology trends and regulatory frameworks in the Global Oncology Information Systems Market?
6. What is the market share of the leading vendors in the Global Oncology Information Systems Market?
7. What modes and strategic moves are considered suitable for entering the Global Oncology Information Systems Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence and prevalence of cancer worldwide
5.1.1.2. Growing adoption of EHRs and other oncology healthcare IT solutions to improve care quality
5.1.1.3. Favorable government mandates and support for oncology information systems
5.1.2. Restraints
5.1.2.1. Dearth of skilled IT professionals in healthcare industry
5.1.3. Opportunities
5.1.3.1. Integration of EMR with treatment planning systems
5.1.3.2. Potential benefits and technological advancements in oncology information systems
5.1.4. Challenges
5.1.4.1. Concerns regarding data privacy and security
5.2. Cumulative Impact of COVID-19
6. Oncology Information Systems Market, by Solutions
6.1. Introduction
6.2. Advanced Visualization & Image Analysis Solutions
6.3. Brachytherapy Treatment Planning Systems
6.4. Chemotherapy Information System
6.5. Clinical Decision Support Systems
6.6. Clinical Integration Solutions
6.7. Laboratory Information Systems
6.8. Oncology Electronic Medical Record (EHR)
6.9. Patient Information Systems
6.10. Picture archiving & communication System (PACS) & VNA
6.11. Population Health Management
6.12. Radiation Dose Management Solutions
6.13. Radiology Information systems
6.14. Radiotherapy Treatment Planning Systems
6.15. Treatment Management Systems & Medical Image Analysis Systems
6.16. Treatment Planning Systems
7. Oncology Information Systems Market, by Service
7.1. Introduction
7.2. Consulting/Optimization Services
7.3. Implementation Services
7.4. Post-Sale & Maintenance Services
8. Oncology Information Systems Market, by Application
8.1. Introduction
8.2. Medical Oncology
8.3. Radiation Oncology
8.4. Surgical Oncology
9. Oncology Information Systems Market, by End User
9.1. Introduction
9.2. Ablation Care Centers & Cancer Care Centers
9.3. Government Institutions
9.4. Hospitals & Diagnostic Imaging Centers
9.5. Research Facilities
10. Americas Oncology Information Systems Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Oncology Information Systems Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Oncology Information Systems Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Accuray Incorporated
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Advanced Data Systems Corporation
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Allscripts Healthcare Solutions, Inc.
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Altai AS
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. CureMD.com, Inc.
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. DOSIsoft SA
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Elekta AB
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. EndoSoft LLC
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Epic Systems Corporation
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. F. Hoffmann-La Roche AG
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Flatiron Health, Inc.
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. GE Healthcare
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. International Business Machines Corporation
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Koninklijke Philips N.V.
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. McKesson Corporation
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. MICA Information Systems, Inc.
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. MIM Software Inc.
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. Oracle Corporation
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. Prowess Inc.
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. RaySearch Laboratories AB
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services
14.21. Siemens Healthineers AG
14.21.1. Business Overview
14.21.2. Key Executives
14.21.3. Product & Services
14.22. UnitedHealth Group
14.22.1. Business Overview
14.22.2. Key Executives
14.22.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing